Overview

A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma

Status:
Terminated

Trial end date:
2018-11-06

Target enrollment:

Participant gender:

Summary

The study will be a single-center, single-arm, Phase II study of gemcitabine and cisplatin in combination with conventional trans-arterial chemoembolization therapy in adult patients with advanced ICC. 25 patients will be enrolled over the course of 2 years, with an additional 1.5 years for patient follow-up.

Phase:

Phase 2

Details

Lead Sponsor:

Yale University

Treatments:

Cisplatin
Doxorubicin
Gemcitabine
Mitomycin
Mitomycins